Congratulations to our client, Rigel Pharmaceuticals Inc. on their appointment of Lisa Rojkjaer, MD to the role of Executive Vice President and Chief Medical Officer
Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer.
C1 Team: Christos Richards, Debbie Lorell,and Todd Aghazadeh